Trial Profile
Motor function optimization in advanced Parkinson's disease patients, combined with galantamine to prevent visual hallucinations.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 31 Oct 2011
Price :
$35
*
At a glance
- Drugs Galantamine (Primary) ; Levodopa/carbidopa
- Indications Hallucinations; Parkinson's disease
- Focus Therapeutic Use
- 05 Aug 2011 New trial record